167results about How to "No immune rejection" patented technology

The invention provides a medical anti-sticking membrane and a preparation method thereof. The anti-sticking membrane comprises a nanometer frame and hydrosol attached thereon. The hydrosol is internally packed with one or several kinds of styptic medicament or/and anti-sticking medicament. The invention also provides a preparation method of the anti-sticking membrane, comprising the following steps of: preparing electro-spinning solution, styptic medicament and/or anti-sticking medicament-containing hydrosol solution and crosslinker solution; receiving static spinning with the crosslinker solution to obtain the nanometer frame; printing the styptic medicament and/or anti-sticking medicament-containing hydrosol solution onto the nanometer frame by an ink-jet printer, and solidifying the hydrosol solution to obtain the anti-sticking membrane. The anti-sticking membrane has good capability and biological compatibility, and nontoxicity as well as nonirritant, can be completely degraded and absorbed, is compounded with controllably released styptic medicament or/and anti-sticking medicament, has controllable degrading time and speed, and conquers defects of the prior art.

The invention provides a nanometer bionic wound-surface cover and a preparation method thereof. The nanometer bionic wound-surface cover comprises a nanometer bionic bracket and hydrosol attached to the bracket, wherein the hydrosol covers one or a plurality of cytokines. The preparation method for the nanometer bionic wound-surface cover provided by the invention comprises the steps of preparingan electrostatic-spinning solution, a cytokine-containing hydrosol solution and a crosslinker solution, preparing the nanometer bionic bracket by use of electrostatic spinning, using an ink-jet printer to print the cytokine-containing hydrosol solution onto the nanometer bionic bracket, and the like, wherein electrostatic spinning and printing can be repeated so as to form the wound-surface covers different in thickness. The preparation method adopts an in-situ autologous stem-cell engineering technique and adopts stem-cell chemotactic factors to attract autologous stem cells to directionally migrate, enter a wound surface and be differentiated according to designed requirements, thereby avoiding inconvenience caused by using viable cells, achieving rehabilitation effects the same with orbetter than that of using the viable cells and having broad application prospects.

The invention provides a tissue engineering nerve graft based on a biological printing technology and a preparation method thereof. The tissue engineering nerve graft comprises an outer tube and a tube inside scaffolds, wherein trophic factors and/or cells can cover the inner surface and the outer surface. A high-fidelity printing operation is performed according to the actual nerve shape demand by utilizing the biological printing technology, a polymer solution is printed into the specified nerve graft in a three-dimensional way by using an ink-jet printer by adjusting the sizes and the quantity of the jet nozzles of the ink-jet printer, the distances from the jet nozzles to a bottom layer and the pulse frequency of a supercharger and writing a control program of specific printing, and the specified nerve graft is applied to treatment of peripheral nerve defect and spinal cord injury.

The invention relates to an acellular biological patch, a preparation method and an apparatus thereof. In the invention, small intestines of pigs are taken as raw materials, which are subjected to a series of decellularization treatment by means of an acid, hydrogen peroxide, a mixed solution of high salt and alkali so as to obtain the acellular biological patch. According to the preparation method, after treatment by the hydrogen peroxide, the mixed solution of high salt and alkali can be employed to conduct twice recycling treatment, thus reaching the effects of thorough decellularization and antigen removal. The employment of a transverse and longitudinal alternating laying way maintains uniformity of the patch's mechanical properties, the tensile strength, suture tear force, tear strength and other mechanical indexes can well meet clinical demands, thus facilitating surgical suture operation. The employed drying mode has no need of any adhesive and suture line for fixation, so that a natural three-dimensional support structure of the product is maintained, and after implantation into the human body, no strong inflammatory response and immunological rejection response can occur. The patch has no toxicity on cells, so that infection and adhesion cannot occur in a repair process. The acellular biological patch provided in the invention is suitable for repair of body tissue defects and soft tissue injuries, and also can be used in the bioengineering field to serve as the tissue for reinforcing repair of membranous defects and infected wounds and serve as a biological scaffold material, etc.

The invention discloses a method for preparing injectable chitosan/sodium glycero-phosphate/collagen hydrogel, belonging to the field of biotechnology and tissue engineering; the invention particularly relates to a technology for preparing temperature sensitive type injectable material. The method is characterized in that 2.2% (W/V) of chitosan solution is mixed with 50% (W/V) of beta-sodium glycero-phosphate solution at low temperature to prepare chitosan/sodium glycero-phosphate solution; then, the solution is mixed with collagen solution following a volume ratio of 1:10-10:1 at low temperature; the mixture is retained in the liquid state at room temperature( 8 DEG C) and is turned into gel at body temperature within 12min. The invention has the beneficial effects that the chitosan/sodium glycero-phosphate/ collagen hydrogel can be maintained in the liquid state at low temperature when pH value is within physiological range (pH value ranges from 7.0 to 7.2); the mixture is turned into gel when the temperature is raised to body temperature (37 DEG C). As ideal cell growth substrate collagen is added, the hydrogel features fine biocompatibility.

The invention discloses a method and application for inducing human umbilical cord mesenchyme stem cells to be differentiated into testicular interstitial cells. The method comprises the following step of culturing human umbilical cord mesenchyme stem cells of patients suffering from adenovirus and carrying mice steroidogenic factor-1 genes in a DMEM-F12 culture solution containing 0.3-3ng/ml of luteinizing hormone, 200-800mu M of dibutyryl cyclic adenosine monophosphate, 5*10<-6>-5*10<-4>M of all-trans retinoic acid (ATRA), 10mU/ml of human chorionic gonadotropin and 2.4uM of adrenocorticotrophic hormone for a week. Induced by the method in the invention, the human umbilical cord mesenchyme stem cells can be differentiated into testicular interstitial cells in vitro and provides important sources of cells for treating testosterone shortage by the cell replacing method or the genetic method.

The invention discloses a chitosan artificial nerve graft containing a neurotrophic factor and a preparation method thereof. In the chitosan artificial nerve graft, chitosan is processed into a nerve conduit with a porous structure and high tensile strength by performing processes such as weak acid dissolving, injection molding, molding, neutralization fixing, cleaning, freeze drying and the like under the condition of not adding any foaming agent or crosslinking agent. The nerve conduit contains cells or tissues which have treating effects and are included or distributed inside or on the surfaces of tubular body pores, including autologous bone marrow stem cells, autologous bone mesenchymal stem cells, schwann cells or dorsal root ganglion tissues or combinations thereof. A tissue engineering nerve can be used for repairing peripheral nerve defect and can be applied to repairing of spinal cord injury simultaneously.

The invention provides a preparation method of a duramater/spinal dural transplanting substitute which is obtained by repeated freezing and thawing of dural tissue, rolling and cracking of cells, crosslinking fixed protection, accellular antigen extraction, dense surface fibrosis modification, packaging and sterilization, and has the advantages of simple method, wide raw material sources, cheap raw materials, and low cost. The prepared dural substitute completely removes components of cells and other antigen components simultaneously when protecting dural tissue natural structure and properties, is good in biocompatibility, free of immune rejection, safe and reliable, good in mechanical performance, and easy in clinical operation, can meet the needs of defect repair, has the function of promoting tissue regeneration as a loose surface is beneficial to the tissue fluid adsorption, active factor enrichment, and growth of blood vessels and cells, and has the advantages of rapidness in fusion with a host, biodegradable absorption, and good repair effect. The animal test shows that the defect can be completely repaired without brain or spinal fluid leakage, or adhesion with brain tissue, and significant rejection is not found.

The invention relates to umbilical cord mesenchymal stem cell injection and a preparation method and application thereof. The injection comprises umbilical cord mesenchymal stem cells and mixed solution; the mixed solution comprises balanced electrolyte solution, hydroxyethyl starch, adenosine disodium triphosphate-magnesium chloride, dimethyl sulfoxide and human serum albumin. The preparation method comprises the following steps: (1) fully and evenly mixing the balanced electrolyte solution, the hydroxyethyl starch and the human serum albumin, and performing filtration sterilization; (2) adding the umbilical cord mesenchymal stem cells; (3) adding the dimethyl sulfoxide; (4) performing split charging and frozen preservation to finish preparation; the invention also provides the application of the injection in the aspect of drugs for treating chronic ischemic heart diseases. The injection disclosed by the invention has a very good resuscitation effect after the frozen preservation, can be directly injected after being unfrozen and resuscitated, and has a remarkable effect on treatment on the chronic ischemic heart diseases.

The invention discloses preparation and application of a nerve tissue matrix derived tissue engineering scaffold material. A nerve tissue is taken as a raw material, matrix components (including nano-scale collagen microfilaments, fibronectin microfilaments and laminin microfilaments) favorable for nerve regeneration are extracted by means of medicine expansion, mechanical pulverization, enzymolysis treatment, dialysis collection and the like, and immunogenicity components (including Schwann cells, phospholipid and axons) not favorable for nerve regeneration are removed. The prepared nerve tissue matrix derived material can be further prepared into a three-dimensional porous oriented scaffold through oriented crystallization, freeze drying and crosslinking separately or by matching other polymer materials, or is prepared into a nano-scale film by an electrospinning technology, and the film is wound to form a nerve regeneration catheter. The tissue engineering scaffold or catheter prepared by the method is favorable for adhesion, proliferation and migration of seed cells, promotes nerve generation and can be used for never defect repair.

The present invention relates to a polypeptide, a production method and uses thereof, wherein the polypeptide comprises an N-terminal region and a C-terminal region, and has remarkable cell adhesion effect.

The present invention provides a functional tissue engineering material for nerve repair. The functional tissue engineering material comprises human amnion, a neurotrophic factor specifically bound with the collagen, and an inhibitor fixedly bound with calpain. The present invention further provides a preparation method for the functional tissue engineering material, wherein neurotrophic factor fusion protein specifically bound with the collagen binding domain and an inhibitor for cross-linking calpain are constructed to form the functional tissue engineering material for guiding nerve repair, such that the human amnion can be specifically bound with the neurotrophic factor so as to effectively promote nerve repair, the regeneration nerve forms correct synaptic connections, the nerve re-injury effect of calpain can be eliminated, and the material can be used for targeting treatment of central nerve injury diseases and neural function repair.

The invention discloses injectable chitosan/keratin composite hydrogel capable of promoting myocardium repair and a preparation method of the hydrogel. The hydrogel consists of four solutions, namely chitosan, sodium beta-glycerophosphate, genipin and keratin according to a volume ratio of 10: (1-5): (1-3): (0.1-0.5). The preparation method comprises the following steps: 1) extracting keratin from human fairs by using peracetic acid and Tris alkaline; 2) adjusting the pH value of a water-soluble chitosan solution by using sodium beta-glycerophosphate so as to be close to a microenvironment in a human body; 3) introducing genipin as a crosslinking agent, and controlling the gelling time of a hydrogel solution by changing the use amount of the genipin so as to achieve the purpose that the mixed solution can be rapidly gelled in situ after being injected into an organism. Experiments prove that the composite hydrogel has favorable biocompatibility and has the capability of remarkably promoting the growth of myocardial cells; the hydrogel is wide in sources of materials and low in cost and has a broad application prospect in the field of tissue engineering repair.

The invention relates to a stem cell repairing material as well as a preparation method and application thereof. The stem cell repairing material comprises a stem cell and a cell carrier, wherein the stem cell is an autologous adipose-derived mesenchymal stem cell (ADSC) with a concentration of 105-108/ml, and the cell carrier is autoserum, normal saline (0.9%) or a glucose injection (5%). In the invention, adopted seed cells are prepared through separating and purifying autologous adipose tissues of patients, thereby avoiding the ethical disputes and the immunological rejection. The material drawing of the adipose tissues can be performed by using an instrument suction method, which is simple in operation and can bring less traumas and pains to the patients. The cell carrier used in the invention is the autoserum, normal saline (0.9%) or glucose injection (5%), therefore, the cell carrier mixed with mesenchymal stem cells and other ingredients can be injected into the patents by virtue of syringes. By using the stem cell repairing material provided by the invention, the operation process is simple, no scar is left, and the wounds and pains for the patients are avoided, therefore, the stem cell repairing material can be easily accepted by the patients.

The invention provides a recombinant humanized III-type collagen. The recombinant humanized III-type collagen has a triple helix structure, and has an amino acid sequence reducing a humanized III-typecollagen alpha-1 chain and including 1068 amino acids. The invention further provides a preparation method of the recombinant humanized III-type collagen, wherein the prolyl hydroxylase of PBCV-1 includes 209 amino acids, and the base sequence is optimized according to the codons of saccharomyces cerevisiae. Compared with the prior art, the preparation method has the advantages that the triple helix is formed in vitro from collagen chains by utilizing the prolyl hydroxylase; and the saccharomyces cerevisiae expression system adopted by the invention is applicable to large-scale amplificationwithout endotoxin or later removal, the preparation cost is low, and the protein expression quantity is further improved. The recombinant humanized III-type collagen is excellent in stability, the amino acid composition of the recombinant humanized III-type collagen is almost completely the same as that of the alpha-1 chain of a natural collagen, and no immunological rejection can be generated when the recombinant humanized III-type collagen is applied to a human body. The recombinant humanized III-type collagen is good in biocompatibility and can be widely applied to surgical treatment and cosmetic medical industry.

The invention discloses a culture method of transgenic swine. The culture method at least comprises following steps: swine primary somatic cells are introduced into messenger RNA coded cell reprogramming genes and/or miR302/367 clusters for inductive production of RNA inductive multipotential stem cells; under the effect of Cas9-gRNA and CRE homologous recombinase, swine toxic genes are knock out,and knock of a plurality of human gene segments is carried out, human derived vWF gene is used for replacing swine endogenous vWF gene, and obtaining PERV-virus-inactivated human-immunological-rejection-free coagulation-incompatibility-free genes; clean target cell lines without off-target-effect are selected, and are culture into swine somatic cells; somatic cell nucleus transfer technology is adopted to treat swine somatic cells so as to obtain transgenic swine. The transgenic swine possesses following advantages, permanent PERV virus expression is inhibited permanently, human immunologicalrejection is avoided, and blood coagulation compatibility is achieved, and can be taken as human heterogeneous organ, tissue, and cell donors.

The invention discloses a method for jointly preparing CAR-VGamma9VDelta2T cells and CAR-NKT cells, comprising the steps of 1) adding peripheral blood mononuclear cells to a cell medium, pre-activating VGamma9VDelta2T cells and NKT cells therein, and amplifying the VGamma9VDelta2T cells and NKT cells by selective in-vitro activation; 2) transducing the mixed cells of step 1) by using a lentiviral vector carrying chimeric antigen receptor's gene sequence. It is possible to carry out standard and batch preparation herein by using GammaDeltaT of a healthy donor; the purities of the VGamma9VDelta2T cells and NKT cells in the application can reach 60% and 30% and above respectively without purification, and therefore pre-purification can be omitted; in-vivo activation proliferation level and existence time of CAR-VGamma9VDelta2T cells and CAR-NKT cells jointly prepared by using the method can be controlled through clinical medication.

The invention relates to a nerve stem cell injection made from retina pigment epithelial cell, to treat paralysis agitans, wherein said injection at least comprises 3*106 nerve stem cells of human hRPE, while said nerve stem cells are cultivated from retina pigment epithelial cells. And its production comprises that: (1), separating and cultivating cells, that separating the hRPE cells, mixing uniformly to prepare single cell suspension; (2), hRPE cell cultivation and generation that digests original cultivation liquid, ending digestion, blowing and beating to form cell suspension, eccentrically filtering and removing the upper clear liquid, adding cultivating substrate, to disperse and form cell suspension, filtering with cell screen, transferring cell into cultivating bottle, generating to at least fifth generation; (3), adding common salt into hRPE nerve stem cell, to prepare cell suspension injection.

A silk fibroin bone nail and a preparing method thereof are provided. The method includes steps of firstly preparing a silk fibroin solution, converting the silk fibroin solution into anhydrous silk fibroin through a freeze-drying process, then dissolving the anhydrous silk fibroin into hexafluoroisopropanol to obtain a hexafluoroisopropanol solution of the silk fibroin, then injecting the hexafluoroisopropanol solution of the silk fibroin into a mold, preparing a silk fibroin rod through methanol treatment and an air drying process, and then cutting the silk fibroin rod into the bone nail. Through adjusting the molecular weight and curing parameters, mechanical performance and the degradation speed of the silk fibroin can be adjusted and controlled to meet different clinical needs. The silk fibroin bone nail having high strength, good brittleness and good human body tissue compatibility can be prepared by the method.

The invention discloses a tissue engineering nerve graft with a suspension fiber scaffold. The nerve graft comprises a conduit and tube fiber scaffolds. The nerve graft is characterized in that a plurality of suspensions are arranged on each fiber scaffold along the fiber length direction, and are connected with the inner wall of the conduit; and the fiber scaffolds are distributed and suspended in the conduit by virtue of the suspensions. By utilizing bio-printing technology, built-in microfilaments of a tissue engineering nerve graft can be stably and uniformly distributed in the conduit by utilizing the supporting force of the suspensions, and each fiber scaffold has an independent space to guarantee that nerve cells can directionally grow along the fiber scaffolds and cannot have error bridging, so that the success rate of operations can be greatly improved.

The invention provides a preparation method for a degradable three dimensional fiber scaffold capable of promoting the repair of bone defects bone defect, and relates to a preparation method for a nano fiber scaffold material based on an electrospinning technique. The preparation method combines a biological material of polyhydroxybutyrate-hydroxyvalerate copolyester (PHBV) which is degradable, has no immunogenicity but cannot induce osteogenesis, polyoxyethylene (PEO) which has good water solubility and can promote the scaffold to be degraded rapidly and hydroxyapatite (nHA) which has bone conductive capacity but need a certain vector. An electrospinning fiber membrane with nano-scale diameter is obtained via an electrostatic spinning method; and finally a multilayer rod-shaped degradable three-dimensional scaffold material can be obtained via cutting and folding. Animal experiments demonstrate that the scaffold has good biocompatibility and appropriate degradable speed, and can realize the repair of large-size bone defects.